This inventor holds 3 USPTO granted patents and 10 published patent applications and 4 EPO patents. Top assignee: Columbia University. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Innovations by Jonathan Barasch
Introduction
Jonathan Barasch is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of medical science, particularly in the treatment of kidney injuries and iron overload conditions. With a total of 3 patents, Barasch's work has the potential to impact patient care and treatment methodologies.
Latest Patents
Barasch's latest patents include a method for the reactivation of mTOR in acute kidney injury (AKI). This method involves administering a pharmaceutically effective amount of one or more amino acids to treat, prevent, or reduce the incidence of AKI in subjects in need. Another notable patent focuses on mutant NGAL proteins and their uses. These proteins can bind to siderophores, chelate and transport iron, and are excreted in urine. The NGAL mutants not only help in clearing excess iron from the body but also exhibit antibacterial activity, making them useful in treating bacterial infections, such as urinary tract infections.
Career Highlights
Throughout his career, Jonathan Barasch has worked with prestigious institutions, including Columbia University and Cincinnati Children's Hospital Medical Center. His research has been pivotal in advancing our understanding of kidney function and iron metabolism.
Collaborations
Barasch has collaborated with notable colleagues, including Andong Qiu and Andrew Beenken. Their combined expertise has contributed to the development of innovative solutions in medical science.
Conclusion
Jonathan Barasch's contributions to medical innovation through his patents and collaborations highlight his commitment to improving healthcare outcomes. His work continues to pave the way for advancements in the treatment of acute kidney injury and iron overload conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
